SANOVEL Trademark

Trademark Overview


On Monday, September 13, 2004, a trademark application was filed for SANOVEL with the United States Patent and Trademark Office. The USPTO has given the SANOVEL trademark a serial number of 79008059. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, May 12, 2021. This trademark is owned by SANOVEL ILAÇ SANAYI VE TICARET ANONIM SIRKETI. The SANOVEL trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, SKELETO-MUSCULAR DISORDERS, GENERAL INFECTIONS, VIRAL INFECTIONS, CENTRAL NERVOUS SYSTEM DISORDERS, GASTRO-INTESTINAL DISORDERS, FUNGAL DISEASES, ERECTILE DYSFUNCTION, RESPIRATORY DISEASES, ALLERGY, OPHTHALMIC DISEASES, CONTAINING ONE OR MORE OF THE FOLLOWING ACTIVE INGREDIENTS - CROMOLIN SODIUM, AMLODIPIN BESYLATE, ALENDRONATE SODIUM, CHLORAZEPATE DIPOTASSIUM, ATROPINE SULPHATE, ATORVASTATIN CALCIUM, CANDESARTAN CILEXETIL, CEFTRIAXONE SODIUM, EPHEDRINE HCL, GUAIPHENESINE, ZAFIRLUKAST, DONEPEZIL HCL, DIFLUNISAL, DIPYRIDAMOLE, FAMOTIDINE, LOSARTAN POTASSIUM, HYDRO-CHLOROTHIAZIDE, MELOXICAM, PHENYLEPRINE HCL, FEXOFENADINE HCL, INDAPAMIDE, SULFISOXAZOLE, CLOPIDOGREL, LANSOPRAZOLE, CLARITHROMYCIN, FLURBIPROFEN, NIMESULIDE, PANTOPRAZOLE, PARACETAMOLE, PILOCARPINE HCL, LISINOPRIL, PSEUDOEPHEDRINE HCL, CIPROFLOXACIN HCL, SERTRALINE HCL, CYCLOPENTOLATE HCL, DIHYDROERGOTOXINE METHANSULFONATE, TERBINAFINE, TIMOLOL MALEATE...
sanovel

General Information


Serial Number79008059
Word MarkSANOVEL
Filing DateMonday, September 13, 2004
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, May 12, 2021
Registration Number3154206
Registration DateTuesday, October 10, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2006

Trademark Statements


Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, SKELETO-MUSCULAR DISORDERS, GENERAL INFECTIONS, VIRAL INFECTIONS, CENTRAL NERVOUS SYSTEM DISORDERS, GASTRO-INTESTINAL DISORDERS, FUNGAL DISEASES, ERECTILE DYSFUNCTION, RESPIRATORY DISEASES, ALLERGY, OPHTHALMIC DISEASES, CONTAINING ONE OR MORE OF THE FOLLOWING ACTIVE INGREDIENTS - CROMOLIN SODIUM, AMLODIPIN BESYLATE, ALENDRONATE SODIUM, CHLORAZEPATE DIPOTASSIUM, ATROPINE SULPHATE, ATORVASTATIN CALCIUM, CANDESARTAN CILEXETIL, CEFTRIAXONE SODIUM, EPHEDRINE HCL, GUAIPHENESINE, ZAFIRLUKAST, DONEPEZIL HCL, DIFLUNISAL, DIPYRIDAMOLE, FAMOTIDINE, LOSARTAN POTASSIUM, HYDRO-CHLOROTHIAZIDE, MELOXICAM, PHENYLEPRINE HCL, FEXOFENADINE HCL, INDAPAMIDE, SULFISOXAZOLE, CLOPIDOGREL, LANSOPRAZOLE, CLARITHROMYCIN, FLURBIPROFEN, NIMESULIDE, PANTOPRAZOLE, PARACETAMOLE, PILOCARPINE HCL, LISINOPRIL, PSEUDOEPHEDRINE HCL, CIPROFLOXACIN HCL, SERTRALINE HCL, CYCLOPENTOLATE HCL, DIHYDROERGOTOXINE METHANSULFONATE, TERBINAFINE, TIMOLOL MALEATE, TIAMPHENICOL, AZITHROMYCIN, TENOXICAM, FLUCONAZOLE, DIGOXINE, TIOCONAZOLE, DIMENHYDRINATE, QUINIDINE ARABOGALACTANE SULPHATE, QUINIDINE PHENYLETHYL BARBITURATE, DILTIAZEM HCL, BUSPIRONE HCL, AMIODARONE HCL, TRAZODONE, DIFLUPREDNATE, ENOXACIN, LACTULOSE, KETOROLAC, PENTOXIFYLLINE, VITAMIN E, CHLORHEXIDINE, CETRIMIDE, PROPYPHENAZONE, CAFFEINE, CETIRIZINE, PHENYLPROPANOLAMINE, ZOLPIDEM, BACAMPICILLIN HCL, ROXITHROMYCIN, SULTAMICILLIN TOSILATE, ACETYLSALICYLIC ACID, AMPICILLIN NA, SULBACTAM NA, SILDENAFIL CITRATE, AMBROXOL HCL, RIBAVIRIN, LORATADINE, ETODOLAC, OMEPRAZOLE, OXYBUTYNIN CHLORIDE, QUINIDINE SULPHATE, OLANZAPINE, RALOXIFEN, PIOGLITAZONE, MOXIFLOXACIN, ROSIGLITAZONE, SIBUTRAMIN, CARVEDILOL, MONTELUKAST, CITALOPRAM, GLICLAZIDE, CEFACLOR, EZETIMIBE, ROFECOXIB, QUETIAPINE FUMARATE, METFORMIN HCL, ACARBOSE, CHLORPHENIRAMINE MALEATE, NATEGLINIDE, LEFLUNOMIDE, VALSARTAN, CEFAZOLIN SODIUM, DIACEREIN, PAROXETINE, LEVOFLOXACIN, LEVETIRACETAM, ZOLMITRIPTAN, GLIBENCLAMIDE, TIZANIDINE, PERINDOPRIL ERBUMINE, RAMIPRIL, CEFTAZIDIME, CEFUROXIME AXETYL, THIOCOLCHICOSIDE, ACAMPROSATE, ACETYLCYSTEINE, ALPHA CALCIDOL, ALPHA LIPOIC ACID, ARIPIPRAZOLE, ATOMOXETINE, BALSALAZIDE DISODIUM, BUTENAFINE HCL, CALCITRIOL, CARBONYL IRON, FOLIC ACID, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, CEFDINIR, CEFEPIME HCL, CEFIXIME, CEFPODOXIME PROXETIL, CEFPROZIL, CEPHALEXINE MONOHYDRATE, CICLESONIDE, CILAZAPRIL, CILOSTAZOL, CINITAPRIDE, CITICOLINE, CO-ENZYME Q10, DARIFENASIN, DEFERIPRONE, DOTHIEPIN, DULOXETINE, ELETRIPTAN, ESCITALOPRAM, ESOMEPRAZOLE, ETORICOXIB, FELODIPINE, FENOFIBRATE, FERROUS SULPHATE, ZINC SULPHATE, FLUVASTATIN, FROVATRIPTAN, GABAPENTIN, GALANTAMINE, GEMIFLOXACIN, GINKGO BILOBA, GLIMEPRIDE, GRANISETRON, IBANDRONATE, IRBESARTAN, IRON HYDROXIDE POLYMALTOSE, LAMIVUDINE, LAMOTRIGINE, LEVETIRACETAM, LETROZOLE, LINEZOLIDE, MEMANTINE HCL, METOPROLOL, MIDODRINE, MIRTAZAPINE, MIZOLASTINE, MOSAPRIDE CITRATE DIHYDRATE, MYCOPHENOLATE MOFETIL, NEBIVOLOL, NEFAZODONE, NIACIN, NITAZOXANIDE, ONDANSETRON, ORNIDAZOLE, OXCARBAZEPINE, PIMECROLIMUS, PRAVASTATIN, PREGABALIN, RABEPRAZOL, REBAMIPIDE, REPAGLINIDE, RISEDRONATE, RISPERIDONE, RIVASTIGMINE, ROSUVASTATIN, SACCHAROMYCES BOULARDII, TACROLIMUS, TADALAFIL, TAMSULOSIN HCL, TAZAROTEN, TAZOBACTAM SODIUM, PIPERACILLIN SODIUM, TEGASEROD, TELITHROMYCIN, TERAZOCIN, TERIPARATIDE, TOLTERODINE TARTRATE, TOPIRAMATE, TRANDOLAPRIL, TRIMETHAZIDINE, VALACYCLOVIR, VALPROATE SODIUM, VENLAFAXINE, VORICONAZOLE, XIMELAGATRAN, ZALEPLON, ZIPRASIDONE, ZOLEDRONIC ACID

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 13, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSANOVEL ILAÇ SANAYI VE TICARET ANONIM SIRKETI
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTR

Party NameSANOVEL ILAÇ SANAYI VE TICARET ANONIM SIRKETI
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIstanbul
TR

Party NameSANOVEL ILAÇ SANAYI VE TICARET ANONIM SIRKETI
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIstanbul
TR

Trademark Events


Event DateEvent Description
Sunday, November 28, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, November 28, 2021DEATH OF INTERNATIONAL REGISTRATION
Thursday, January 25, 2018NEW REPRESENTATIVE AT IB RECEIVED
Monday, June 1, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, August 27, 2014GENERIC MADRID TRANSACTION SENT TO IB
Wednesday, August 27, 2014GENERIC MADRID TRANSACTION CREATED
Tuesday, May 13, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 13, 2013CANCELLED SECTION 71
Saturday, November 3, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, June 2, 2011INTERNATIONAL REGISTRATION RENEWED
Thursday, June 5, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, May 7, 2007FINAL DISPOSITION NOTICE SENT TO IB
Monday, May 7, 2007FINAL DISPOSITION PROCESSED
Monday, May 7, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 10, 2006REGISTERED-PRINCIPAL REGISTER
Thursday, August 3, 2006NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, July 20, 2006NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, July 20, 2006NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, July 14, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 9, 2006EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, February 21, 2006EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 24, 2006PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2006NOTICE OF PUBLICATION
Wednesday, December 7, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 2, 2005ASSIGNED TO LIE
Monday, November 28, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 27, 2005AMENDMENT FROM APPLICANT ENTERED
Friday, October 14, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 14, 2005PAPER RECEIVED
Monday, June 20, 2005REFUSAL PROCESSED BY IB
Thursday, April 14, 2005NON-FINAL ACTION MAILED
Monday, April 11, 2005NON-FINAL ACTION WRITTEN
Monday, April 11, 2005ASSIGNED TO EXAMINER
Friday, February 18, 2005NEW APPLICATION ENTERED IN TRAM
Thursday, February 17, 2005SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB